Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

971.7000 -0.20 (-0.02%)

NSE Jun 26, 2025 10:42 AM

25.48% Fall from 52W High

Volume: 13,625

Alembic Pharmaceuticals Ltd.

17 Apr 2025

971.70

-0.02%

Company Update

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg

More from Alembic Pharmaceuticals Ltd.

Recommended

Market trades higher, Texmaco Rail bags an order worth Rs 535 crore from Camalco SA

Trendlyne Marketwatch | 26 Jun 2025, 10:35AM

Five stocks to buy from analysts this week - June 25, 2025

The Baseline | 25 Jun 2025, 11:20AM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals